RECRUITING

Use of CGM in Kidney Transplant Recipients

Description

The investigators want to study the impact CGM (continuous glucose monitoring) has on patients glycemic control as determined by time in range (TIR 70-180 mg/dL) in the Diabetic Kidney Transplant population.

Conditions

Kidney Transplant; ComplicationsDiabetes Mellitus, Type 2Insulin Dependent Diabetes
Talk to us

Related Conditions:

Kidney Transplant; ComplicationsDiabetes Mellitus, Type 2Insulin Dependent Diabetes

Study Overview

On this page

Study Details

Study overview

The investigators want to study the impact CGM (continuous glucose monitoring) has on patients glycemic control as determined by time in range (TIR 70-180 mg/dL) in the Diabetic Kidney Transplant population.

Continuous Glucose Monitoring (CGM) to Improve Glycemic Control in Kidney Transplant Recipients

Use of CGM in Kidney Transplant Recipients

Condition
Kidney Transplant; Complications
Intervention / Treatment

-

Contacts and Locations

Sacramento

UC Davis Health, Sacramento, California, United States, 95817

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Age 18 or above
  • 2. Received a kidney transplant within the past year with functioning kidney (eGFR \> 30 mL/min
  • 3. Person with Type 2 Diabetes and on insulin
  • 4. Access to home wi-fi connection
  • 1. Person with Type 1 Diabetes
  • 2. Patients taking hydroxyurea
  • 3. Patient unable to wear the Dexcom G6 device at all times for any reason
  • 4. Must be able to test blood glucose with meter 4x a day when on blinded CGM.
  • 5. Presence of clinically significant visual or cognitive impairment
  • 6. Illiterate
  • 7. Prisoners
  • 8. Women who are pregnant, who plan to become pregnant during the course of the study, or who are breastfeeding
  • 9. Presence of clinically unstable cardiovascular disease
  • 10. Active malignancy treatment

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of California, Davis,

Ling Chen, MD, STUDY_DIRECTOR, UCDavis Transplant Nephrology

Study Record Dates

2025-12-31